BRAVO · MS-LAQ-302
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
Estudio multinacional, multicéntrico, randomizado, de grupos paralelos, realizados en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad de laquinimod frente a placebo con frente a placebo co EUDRACT: 2007-005450-23
Historical record notice: The original Spanish study title is incomplete. It is shown as recorded, without guessing the missing information.
Sponsor: TEVA
Phase: III
Area: Neuroimmunology